Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.200
-0.020 (-1.64%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Climb Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
811217498278-
Upgrade
Market Cap Growth
62.54%62.54%-23.65%-64.90%--
Upgrade
Enterprise Value
-131-97-33-32108-
Upgrade
Last Close Price
1.201.802.703.6710.46-
Upgrade
Debt / Equity Ratio
0.000.000.000.00--
Upgrade
Quick Ratio
30.8330.8338.5721.3523.798.16
Upgrade
Current Ratio
31.4131.4138.9222.0424.588.76
Upgrade
Return on Equity (ROE)
-46.26%-46.26%-29.72%-30.58%-50.16%-96.73%
Upgrade
Return on Assets (ROA)
-10.30%-10.30%-10.93%-18.30%-22.54%-31.96%
Upgrade
Return on Capital (ROIC)
-10.54%-10.54%-11.31%-19.04%-23.55%-34.42%
Upgrade
Buyback Yield / Dilution
-78.47%-78.47%-2.57%-114.60%-460.40%-31.72%
Upgrade
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q